Insider · CIK 0002014773
Jonathan Cherry
Files at PPTA (PERPETUA RESOURCES CORP.). First filing Feb 24, 2025, latest Apr 2, 2026.
Jonathan Cherry files SEC Form 4 as officer and director at PPTA (PERPETUA RESOURCES CORP.). Since Feb 24, 2025, Jonathan Cherry has reported 1 open-market buy worth $9,976 and 2 open-market sells worth $473k, the latest filed on Apr 2, 2026.
A track record needs three past buys with six months of prices behind them; Jonathan Cherry has 0, so none is measured yet.
The newest scored trade: sold $120k of PPTA on Apr 2, 2026, filed Apr 2, 2026, scored 33 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $120k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PPTA: PERPETUA RESOURCES CORP.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | PERPETUA RESOURCES CORP. | $120k 4,079 shares | -8% | +228% from low-21% from high | |
| 40Moderate | PPTAsell PERPETUA RESOURCES CORP. | $354k 14,911 shares | -29% | +194% from low0% from high | |
| 38Weak | PERPETUA RESOURCES CORP. | $9,976 1,160 shares | - | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 2, 2026 | PPTA PERPETUA RESOURCES CORP. | 3,978 0.00% of outstanding | $117k | Apr 2, 2026 | none |
| Oct 6, 2025 | PPTA PERPETUA RESOURCES CORP. | 14,911 0.01% of outstanding | $354k | Oct 6, 2025 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | PPTA PERPETUA RESOURCES CORP. | SOpen-market sale Common Shares | -4,079 | $29.31 | $120k | 44,895 | Apr 2, 2026 |
| Feb 21, 2026 | PPTA PERPETUA RESOURCES CORP. | MOption exercise Common Shares | +12,725 | $0.00 | $0 | 48,974 | Feb 24, 2026 |
| Feb 21, 2026 | PPTA PERPETUA RESOURCES CORP. | MOption exercise Restricted Share Unitsderivative | -12,725 | $0.00 | $0 | 47,088 | Feb 24, 2026 |
| Feb 11, 2026 | PPTA PERPETUA RESOURCES CORP. | AGrant or award Restricted Share Unitsderivative | +21,639 | $0.00 | $0 | 59,813 | Feb 12, 2026 |
| Oct 6, 2025 | PPTA PERPETUA RESOURCES CORP. | AGrant or award Common Shares | +50,000 | $0.00 | $0 | 51,160 | Oct 6, 2025 |
| Oct 6, 2025 | PPTA PERPETUA RESOURCES CORP. | SOpen-market sale Common Shares | -14,911 | $23.72 | $354k | 36,249 | Oct 6, 2025 |
| Feb 21, 2025 | PPTA PERPETUA RESOURCES CORP. | POpen-market purchase Common Shares | +1,160 | $8.60 | $9,976 | 1,160 | Feb 24, 2025 |
| Feb 21, 2025 | PPTA PERPETUA RESOURCES CORP. | AGrant or award Restricted Share Unitsderivative | +38,174 | $0.00 | $0 | 38,174 | Feb 21, 2025 |
Questions about Jonathan Cherry
Answered from the filings on this page, as of the latest one.
Is Jonathan Cherry buying or selling?
In the last 12 months Jonathan Cherry reported 0 open-market buys worth $0 and 1 open-market sell worth $120k on SEC Form 4; the latest was sold $120k of PPTA on Apr 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Jonathan Cherry's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Cherry has 0.
Where does Jonathan Cherry file Form 4?
Jonathan Cherry has filed Form 4 at PPTA (PERPETUA RESOURCES CORP.) as (See remarks (3)). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.